Ozawa H - Search Results

1

IKZF1^plus alterations are not associated with outcomes in Philadelphia-positive acute lymphoblastic leukemia patients enrolled in the FBMTG ALL/MRD2008 trial.

Ito Y, Ozawa H, Eto T, Miyamoto T, Kamimura T, Ogawa R, Uchida N, Wake A, Fujisaki T, Ohno Y, Takase K, Okumura H, Takamatsu Y, Kawano N, Akashi K, Nagafuji K. Ito Y, et al. Among authors: ozawa h. Eur J Haematol. 2023 Jul;111(1):103-112. doi: 10.1111/ejh.13972. Epub 2023 Apr 8. Eur J Haematol. 2023. PMID: 36991564

2

The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages.

Iwasaki H, Mizuno S, Arinobu Y, Ozawa H, Mori Y, Shigematsu H, Takatsu K, Tenen DG, Akashi K. Iwasaki H, et al. Among authors: ozawa h. Genes Dev. 2006 Nov 1;20(21):3010-21. doi: 10.1101/gad.1493506. Genes Dev. 2006. PMID: 17079688 Free PMC article.

3

Notch1 expression is regulated at the post-transcriptional level by the 3' untranslated region in hematopoietic stem cell development.

Mizuno S, Iino T, Ozawa H, Arinobu Y, Chong Y, Akashi K. Mizuno S, et al. Among authors: ozawa h. Int J Hematol. 2018 Mar;107(3):311-319. doi: 10.1007/s12185-017-2358-2. Epub 2017 Nov 2. Int J Hematol. 2018. PMID: 29098541

4

Successful correction of factor V deficiency of patient-derived iPSCs by CRISPR/Cas9-mediated gene editing.

Nakamura T, Morishige S, Ozawa H, Kuboyama K, Yamasaki Y, Oya S, Yamaguchi M, Aoyama K, Seki R, Mouri F, Osaki K, Okamura T, Mizuno S, Nagafuji K. Nakamura T, et al. Among authors: ozawa h. Haemophilia. 2020 Sep;26(5):826-833. doi: 10.1111/hae.14104. Epub 2020 Jul 22. Haemophilia. 2020. PMID: 32700411

5

Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.

Oya S, Morishige S, Ozawa H, Sasaki K, Semba Y, Yamasaki Y, Nakamura T, Aoyama K, Seki R, Mouri F, Osaki K, Miyamoto T, Maeda T, Nagafuji K. Oya S, et al. Among authors: ozawa h. Int J Hematol. 2021 Feb;113(2):285-289. doi: 10.1007/s12185-020-03006-5. Epub 2020 Sep 19. Int J Hematol. 2021. PMID: 32951102

6

Alternating venetoclax/azacytidine and FLT3 inhibitor treatment for NPM1- and FLT3-mutated acute myeloid leukemia.

Oya S, Ozawa H, Maehiro Y, Nakamura T, Takaki Y, Fukuyama T, Yamasaki Y, Yamaguchi M, Aoyama K, Mouri F, Nagafuji K. Oya S, et al. Among authors: ozawa h. Leuk Res. 2023 Jul;130:107313. doi: 10.1016/j.leukres.2023.107313. Epub 2023 May 16. Leuk Res. 2023. PMID: 37207502 No abstract available.

7

CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity.

Oya S, Ozawa H, Nakamura T, Mori A, Ochi S, Maehiro Y, Umeda M, Takaki Y, Fukuyama T, Yamasaki Y, Yamaguchi M, Aoyama K, Mouri F, Nagafuji K. Oya S, et al. Among authors: ozawa h. Int J Hematol. 2024 Aug;120(2):194-202. doi: 10.1007/s12185-024-03803-2. Epub 2024 Jun 10. Int J Hematol. 2024. PMID: 38853211

8

High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia.

Oya S, Ozawa H, Morishige S, Maehiro Y, Umeda M, Takaki Y, Fukuyama T, Yamasaki Y, Nakamura T, Yamaguchi M, Aoyama K, Mouri F, Nagafuji K. Oya S, et al. Among authors: ozawa h. Int J Hematol. 2024 Sep;120(3):297-304. doi: 10.1007/s12185-024-03814-z. Epub 2024 Jul 4. Int J Hematol. 2024. PMID: 38963637

9

CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.

Morishige S, Mizuno S, Ozawa H, Nakamura T, Mazahery A, Nomura K, Seki R, Mouri F, Osaki K, Yamamura K, Okamura T, Nagafuji K. Morishige S, et al. Among authors: ozawa h. Int J Hematol. 2020 Feb;111(2):225-233. doi: 10.1007/s12185-019-02765-0. Epub 2019 Oct 29. Int J Hematol. 2020. PMID: 31664646

10

Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies.

Nakamura T, Oya S, Ozawa H, Maehiro Y, Muta S, Umeda M, Takaki Y, Fukuyama T, Yamasaki Y, Yamaguchi M, Aoyama K, Mouri F, Naito Y, Nagafuji K. Nakamura T, et al. Among authors: ozawa h. Int J Hematol. 2024 Apr;119(4):426-431. doi: 10.1007/s12185-024-03718-y. Epub 2024 Feb 16. Int J Hematol. 2024. PMID: 38363480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,620 results

Search Page

Filters